Fenwick represented Embedded Ventures on the deal. Embedded Ventures, a Los Angeles-based venture capital firm, announced the launch of its inaugural fund. Embedded Ventures will use the...
You must be a Standard 1 Year member to access this content.
Fenwick represented Standard AI on the deal. Standard AI, a developer of autonomous checkout technology designed to streamline operations for brick-and-mortar retailers, announced its definitive agreement to...
You must be a Standard 1 Year member to access this content.
Fenwick represented Supernormal on the deal. Supernormal, a generative AI company that helps capture and share video meetings with live notes, transcript and automatic highlight videos,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Angle Health on the deal. Angle Health, a full-stack health insurance carrier delivering comprehensive healthcare benefits tailored to startups and technology companies, announced its $58...
You must be a Standard 1 Year member to access this content.
Fenwick represented Mythical Games on the deal. Mythical Games, a next-generation gaming technology studio, announced its acquisition of DMarket, a marketplace for trading, gaming and esports digital...
You must be a Standard 1 Year member to access this content.
Fenwick represented Craft on the deal. Craft, an enterprise intelligence company, announced its $32 million Series B financing. The financing was led by BAM Elevate with participation...
You must be a Standard 1 Year member to access this content.
Fenwick represented Jam City on the deal. Jam City, a mobile entertainment company, announced its spin-off of Plai Labs, a new social platform. In conjunction, the company...
You must be a Standard 1 Year member to access this content.
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
You must be a Standard 1 Year member to access this content.
Fenwick and Goodwin represented Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Lashify on the deal. Lashify, an award-winning beauty technology brand and inventor of the world’s first DIY lash extension system, obtained a victory in an...
You must be a Standard 1 Year member to access this content.
Fenwick represented Perceive Bio on the deal. Perceive Bio, a biotech company pioneering novel technologies and therapeutics in ophthalmology, announced its $78 million Series B financing. The...
You must be a Standard 1 Year member to access this content.
Fenwick represented Belharra Therapeutics on the deal. Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with...
You must be a Standard 1 Year member to access this content.
